Philippine FDA CPR Renewal Rule: Advisory 2026-1007

The FDA CPR renewal rule is narrower than a general grace period. A medical-device certificate can remain valid after its printed expiry while FDA review is pending, but only when the renewal was filed within the stated 120-day window and the applicable charges were paid. Advisory 2026-1007 also tells importers, suppliers and bid teams what evidence they may present.

The signed advisory bears the date 28 July 2026. The FDA website listed it on 28 August. Keeping those dates separate matters because the legal instrument and the web posting are not the same record.

The Center for Device Regulation, Radiation Health, and Research issued the clarification for manufacturers, traders, distributors, importers, customs authorities, procuring entities and other government agencies. The document points back to the implementing rules of Republic Act No. 9711. FDA says the underlying continued-validity rule already existed.

This FDA CPR renewal clarification deals with a familiar desk-level problem. The certificate in a shipment or tender file may show an expired date even though the holder filed a timely renewal and FDA has not yet decided it. Advisory 2026-1007 sets out the conditions and the supporting records for that interval.

01A CPR can remain valid after the printed expiry

The advisory quotes Book II, Article I, Section 3.B, Item (2) of the IRR. A renewal filed within 120 days from the CPR’s original expiry is considered valid and existing until FDA renders a decision or resolution on the application.

FDA then makes the rule more concrete. Continued validity applies when the renewal was filed within that period and the applicable renewal fees, surcharges and penalties, if any, were paid. The status lasts only while the application remains unresolved.

Under the FDA CPR renewal test, an application number alone does not establish the whole status. The filing date must fit the 120-day rule, and the payment trail must cover the charges that apply to the case.

02“Renewal pending” is too vague for a transaction file

Regulatory teams often use “renewal pending” as shorthand. That phrase leaves out the facts a customs desk or procurement committee needs. Was the application filed on time? Were the charges paid? Has FDA already issued a decision?

A broker who receives only the expired CPR cannot reconstruct that answer from the certificate. The same problem arises in public bidding when the bid file contains the old certificate but omits the FDA acknowledgment or the payment receipt. The advisory gives the holder a way to close that gap.

One point remains open in the text. The document says “days” but does not state whether it means calendar days or working days. It also does not set a processing timeline or list the portal steps. A holder should confirm the current CDRRHR procedure instead of planning around the last possible day.

03What customs, procurement and bid teams may ask to see

For importation, procurement, public bidding, supply and delivery, and other government transactions requiring proof of product registration, Advisory 2026-1007 identifies two records that may be presented:

• Proof of submission or FDA acknowledgment
  A record issued by FDA showing that the renewal application was received.
  Record 1
• Proof of payment
  A receipt or equivalent evidence for the applicable renewal fee, surcharge and penalty, where applicable.
  Record 2

Those records support the claim that the CPR remains valid while FDA action is pending. They do not force a receiving agency to accept the file without checking it. Point 5 of the advisory preserves the authority of the concerned agency or entity to verify the documents and the application status with FDA.

04The weak point is usually the hand-off between teams

The rule itself is simple. The file is where companies can still fail.

Regulatory affairs may hold the FDA acknowledgment. Finance keeps the receipt. Logistics sees an expired CPR. The sales team submits a tender before anyone has matched the product name, model, holder and application reference across the three records. Every document may exist, yet the transaction file remains incomplete.

Advisory 2026-1007 gives these teams a common test. It can reduce avoidable disputes caused by treating the printed expiry as the only status field. It does not guarantee clearance of a shipment or acceptance of a bid; the receiving body retains its verification role.

05Late filing sends the product back to the initial route

The 120-day limit has a hard consequence in the advisory. A renewal filed beyond 120 days from the original expiry is treated as expired and becomes subject to the applicable initial-filing and evaluation procedures under the IRR.

A payment receipt cannot substitute for timely filing. Likewise, filing within the period does not create open-ended validity. The interim status ends when FDA renders its decision or resolution, so the transaction file must be updated as soon as that happens.

06CPR, CMDN and CMDR should not be collapsed into one label

Advisory 2026-1007 uses the term CPR throughout. Current Philippine device regulation also uses the Certificate of Medical Device Notification, or CMDN, and the Certificate of Medical Device Registration, or CMDR.

FDA’s 2025 eServices notice identifies CMDN for Class A medical devices and CMDR for Class B, C and D devices. An earlier FDA circular also recognises CPR, CMDR and CMDN as medical-device authorizations.

The safe reading is literal: apply Advisory 2026-1007 to the authorization it names, then check the current CDRRHR route for a file carrying a CMDN or CMDR. Silently renaming every device authorization as a CPR creates a preventable documentation error.

07What an FDA CPR renewal file should contain

The advisory expressly identifies two supporting records: FDA proof of submission or acknowledgment, and proof of payment. The remaining items below are internal controls. They help a company present the two required records against the correct product and certificate.

• Original CPR
  Retain the certificate and its original expiry date.
  Base record
• FDA acknowledgment
  Preserve the application number, filing date and product identity.
  FDA record
• Payment evidence
  Match the receipt to the application and include other applicable charges.
  FDA record
• Product reconciliation sheet
  Check holder name, device name, model, variants and certificate number across the file.
  House control
• Latest status evidence
  Keep the most recent portal output or FDA correspondence available to the holder.
  House control
• Decision alert
  Assign one owner to replace the pending file when FDA resolves the application.
  House control

08Witfire view: a small clarification with transaction value

The legal rule was already in the IRR. The advisory’s value is more practical: it tells an importer or procurement officer which evidence can support the CPR after the printed expiry date has passed.

That sounds administrative. It is. Administrative gaps can still hold a shipment, weaken a bid or delay delivery. A company relying on FDA CPR renewal status needs one reconciled file, not separate fragments in regulatory, finance and logistics inboxes.

The protection is also easy to overstate. It fails when the filing falls outside the stated period or the applicable charges remain unpaid. It ends when FDA decides the renewal. The document pair supports an interim status; it does not convert that status into approval.

09FAQ

Can a medical-device CPR remain valid after its printed expiry?

Yes, when the renewal was filed within 120 days from the original expiry, the applicable fees and other charges were paid, and FDA has not yet rendered a decision or resolution.

What is FDA Advisory No. 2026-1007?

It is a CDRRHR clarification on the continued validity of medical-device CPRs while renewal applications remain pending. The signed instrument is dated 28 July 2026; the FDA website listed it on 28 August 2026.

What does the FDA CPR renewal guidance require?

The application must have been filed within 120 days from the CPR’s original expiry, and the applicable renewal fees, surcharges and penalties, if any, must have been paid.

Which records can be shown for importation or public bidding?

The advisory identifies FDA proof of submission or acknowledgment of the renewal application and proof of payment of the applicable charges.

Can customs or a procurement entity verify the records?

Yes. The advisory preserves the authority of the concerned agency or entity to verify the authenticity of the documents and the application status with FDA.

Does a pending renewal mean FDA has approved it?

No. Continued validity during review is an interim status. It ends when FDA renders a decision or resolution.

What happens when the renewal was filed beyond 120 days?

The advisory says the CPR is considered expired and the application becomes subject to the applicable initial-filing and evaluation procedures.

Does the advisory define calendar days or working days?

No. It uses the word “days” without defining the counting convention in the text. Holders should confirm the applicable CDRRHR process rather than assume a deadline calculation.